Janus Henderson Group
CRDF icon

Janus Henderson Group’s Cardiff Oncology CRDF Stock Holding History

Janus Henderson Group’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,742,123
Closed -$4.32M – 2613
2022
Q1 		$4.32M Sell
1,742,123
-1,780,889
-51% -$6.3M ﹤0.01% 1042
2021
Q4 		$21.2M Sell
3,523,012
-10,369
-0.3% -$61.8K 0.01% 772
2021
Q3 		$23.5M Buy
3,533,381
+382,214
+12% +$2.4M 0.01% 754
2021
Q2 		$21M Buy
3,151,167
+213,985
+7% +$1.81M 0.01% 777
2021
Q1 		$27.2M Buy
2,937,182
+799,511
+37% +$9.71M 0.01% 703
2020
Q4 		$38.4M Buy
2,137,671
+1,124,853
+111% +$19.8M 0.02% 603
2020
Q3 		$14.4M Buy
+1,012,818
New +$6.69M 0.01% 770

Other funds holding CRDF

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Janus Henderson Group's CRDF Position: Q2 2022 in Review

Janus Henderson Group sold out of Cardiff Oncology (CRDF) in Q2 2022, closing a stake of 1,742,123 shares — an estimated $4.32M sold.

Janus Henderson Group first reported a position in CRDF in Q3 2020 and held it in 7 quarters. The position peaked at $38.4M in Q4 2020. 67 funds tracked by Wall St. Rank hold CRDF as of Q2 2022.

  • Janus Henderson Group reported no remaining Cardiff Oncology position as of Q2 2022 after selling out during the quarter.
  • Janus Henderson Group sold 1,742,123 Cardiff Oncology shares in Q2 2022, an estimated $4.32M.
  • Janus Henderson Group first reported a position in Cardiff Oncology in Q3 2020 and held it in 7 quarters.
  • Janus Henderson Group's Cardiff Oncology position peaked at $38.4M in Q4 2020.
  • 67 funds tracked by Wall St. Rank held Cardiff Oncology as of Q2 2022.

Based on Janus Henderson Group's 13F filing for Q2 2022, filed 15 Aug 2022.